COSMOS PharmaceuticalCOSMOS Pharmaceutical Corporation3349東証プライム小売業FY ending May 2026, consolidated, J-GAAP

What does COSMOS Pharmaceutical do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥58.8B
Capex
¥70.5B
of revenue 6.4%
Free cash flow
-¥11.7B
Returned to shareholders
¥5.94B
of net income: 19%
Dividend per share
¥82
Payout ratio (reported)
20.3%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥32B
Operating cash flow¥58.8B
Cash conversion (operating CF ÷ operating income)
138.8%
Cash vs. profit gap
¥26.7B(純利益の 83.5%)
Shareholder returns
of net income 18.5%
Shareholder payments — dividends
of net income 18.5%
CapEx intensity (capex ÷ revenue)
6.4%
Investing CF relative to operating CF
139.3%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥58.8B
FY ending May 2022: ¥32.2B¥32.2BFY ending May 2023: ¥54.4B¥54.4BFY ending May 2024: ¥55.2B¥55.2BFY ending May 2025: ¥52.5B¥52.5BFY ending May 2026: ¥58.8B¥58.8BFY22FY23FY24FY25FY26
Free cash flow-¥11.7B
FY ending May 2022: -¥11.3B-¥11.3BFY ending May 2023: ¥7.8B¥7.8BFY ending May 2024: -¥635M-¥635MFY ending May 2025: -¥859M-¥859MFY ending May 2026: -¥11.7B-¥11.7BFY22FY23FY24FY25FY26
Net income¥32B
FY ending May 2022: ¥23.2B¥23.2BFY ending May 2023: ¥23.8B¥23.8BFY ending May 2024: ¥24.5B¥24.5BFY ending May 2025: ¥31B¥31BFY ending May 2026: ¥32B¥32BFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第44期(2025/06/01-2026/05/31)

    ID S100YYDI2026-08-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第43期(2024/06/01-2025/05/31)

    ID S100WLSP2025-08-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第42期(2023/06/01-2024/05/31)

    ID S100UAMF2024-08-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第41期(2022/06/01-2023/05/31)

    ID S100RS022023-08-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第40期(令和3年6月1日-令和4年5月31日)

    ID S100P3732022-08-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第39期(令和2年6月1日-令和3年5月31日)

    ID S100MD0R2021-08-30Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.